Chronic autoimmune conditions such as rheumatoid arthritis can significantly impact daily life by causing persistent joint pain, swelling, stiffness, and gradual joint damage. Early and effective disease control is essential to slow disease progression and maintain long-term joint function. LEFLUNOMILE 20, containing Leflunomide 20 mg, is a well-established Disease-Modifying Anti-Rheumatic Drug (DMARD) designed to manage autoimmune inflammatory conditions effectively.
Leflunomide works by targeting the underlying immune mechanisms responsible for inflammation, rather than only providing symptomatic relief. LEFLUNOMILE 20 helps reduce joint inflammation, controls disease activity, and improves mobility in patients suffering from rheumatoid arthritis. Manufactured with strict quality standards, this medication is widely prescribed by healthcare professionals across India for long-term disease management.
Uses of LEFLUNOMILE 20
LEFLUNOMILE 20 Leflunomide 20 mg is primarily used for the treatment of autoimmune and inflammatory joint disorders. Its major uses include:
Management of Rheumatoid Arthritis (RA) in adults
Reducing joint swelling, pain, and morning stiffness
Slowing down joint damage and disease progression
Improving physical function and quality of life
Long-term control of autoimmune inflammation
By suppressing abnormal immune responses, LEFLUNOMILE 20 helps prevent further damage to joints and surrounding tissues.
Benefits of LEFLUNOMILE 20
LEFLUNOMILE 20 offers multiple therapeutic benefits, making it a reliable choice for chronic inflammatory arthritis management:
Controls Autoimmune Inflammation
Leflunomide inhibits the activity of immune cells responsible for inflammation, helping reduce swelling and pain in affected joints.
Slows Disease Progression
Unlike pain relievers, LEFLUNOMILE 20 works at the disease level, helping prevent long-term joint damage and deformities.
Improves Joint Mobility
Regular use can significantly improve joint flexibility, reduce stiffness, and enhance daily movement.
Reduces Dependency on Steroids
By effectively controlling inflammation, it may help reduce the need for long-term corticosteroid use.
Enhances Quality of Life
Patients experience better physical function, reduced fatigue, and improved ability to perform daily activities.
Once-Daily Convenience
The 20 mg dosage allows easy once-daily administration, supporting better patient compliance.
Dosage of LEFLUNOMILE 20
The dosage of LEFLUNOMILE 20 should always be determined by a qualified healthcare professional based on the patient’s condition and response to therapy.
The usual maintenance dose is one tablet (20 mg) once daily
Tablets should be swallowed whole with water
It can be taken with or without food
Consistent daily intake at the same time is recommended
Patients should not alter the dose or stop treatment abruptly without consulting their doctor, as rheumatoid arthritis requires long-term management.
Side Effects of LEFLUNOMILE 20
Like all medications, LEFLUNOMILE 20 may cause side effects in some individuals. Most side effects are mild and manageable, especially with regular monitoring.
Common Side Effects
Diarrhoea
Nausea or stomach discomfort
Headache
Mild hair thinning
Increased liver enzyme levels
Less Common Side Effects
Skin rash
Weight loss
High blood pressure
Reduced white blood cell count
Regular blood tests are usually advised to monitor liver function and blood counts during treatment.
Precautions and Warning
Before starting LEFLUNOMILE 20, certain precautions should be considered to ensure safe use:
Not recommended in patients with severe liver disease
Avoid alcohol consumption as it may increase liver-related risks
Regular liver function tests are essential during therapy
Use with caution in patients with weakened immune systems
Women of childbearing age should use effective contraception
Not recommended during pregnancy or breastfeeding
Inform the doctor about all ongoing medications and supplements
Patients should immediately report symptoms such as persistent nausea, yellowing of skin or eyes, severe fatigue, or unexplained infections.
Conclusion
LEFLUNOMILE 20 Leflunomide 20 mg is a proven and effective disease-modifying therapy for the management of rheumatoid arthritis and autoimmune joint disorders. By addressing the root cause of inflammation, it helps reduce pain, slow disease progression, and preserve joint health over the long term.
With consistent use under medical supervision, LEFLUNOMILE 20 can significantly improve mobility, reduce disability, and enhance overall quality of life. Its once-daily dosing and strong clinical profile make it a trusted choice among healthcare professionals for long-term arthritis management.
